The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

The new project voted ahead by township officials Monday night is planned for roughly a block east, in the Merck campus on ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...

A former Harvard Medical School professor who claims he was fired for refusing to receive the Covid-19 vaccine was appointed ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

Among the eight people who Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US Centers for Disease Control and Prevention are an emergency physician who ...

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...

A federal judge in California ordered the State Department to temporarily hold off on firing nearly 1,900 employees as planned. Read more › Voter ID: A federal judge on Friday indefinitely blocked ...

Protein deficiency is rare in the United States, but some people are at risk for it. Learn the symptoms of protein deficiency ...